Urinary concentration of transforming growth factor‐β‐inducible gene‐h3(βig‐h3) in patients with Type 2 diabetes mellitus

Aims  The expression of TGFβ‐inducible gene h3(βig‐h3) has been used to assess the biological activity of TGFβ in the kidney. In this study, we investigated whether the urinary concentration of βig‐h3 is associated with diabetic nephropathy in patients with Type 2 diabetes mellitus. We also evaluated the relationship between the urinary concentration of βig‐3 and proteinuria and microalbuminuria (AER) in a normal healthy population and in Type 2 diabetes patients.

[1]  In‐San Kim,et al.  TGF‐β‐induced protein βig‐h3 is upregulated by high glucose in vascular smooth muscle cells , 2003 .

[2]  Christine M. Hoehner,et al.  Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. , 2002, Journal of the American Society of Nephrology : JASN.

[3]  R. Gilbert,et al.  Transforming growth factor-β1 and tumor growth factor-β-inducible gene-h3 in nonrenal transplant cyclosporine nephropathy , 2001 .

[4]  Kyung Rim Shin,et al.  Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study , 2001, Journal of hypertension.

[5]  J. H. Kim,et al.  Overexpression of the transforming growth factor-beta-inducible gene betaig-h3 in anterior polar cataracts. , 2000, Investigative ophthalmology & visual science.

[6]  E. Ritz,et al.  Nephropathy in patients with type 2 diabetes mellitus. , 1999, The New England journal of medicine.

[7]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[8]  A. Gressner,et al.  Expression of different isoforms of TGF-β and the latent TGF-β binding protein (LTBP) by rat Kupffer cells , 1998 .

[9]  David W. Johnson,et al.  Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats1 , 1998 .

[10]  Domínguez,et al.  Transforming growth factor‐β (TGF‐β) activity in urine of patients with glomerulonephritis is related to their renal functional and structural changes , 1998 .

[11]  J. Widimský,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.

[12]  H. Abboud,et al.  Expression of Transforming Growth Factor-β and Type IV Collagen in Early Streptozotocin-Induced Diabetes , 1997, Diabetes.

[13]  T. Zderic,et al.  βig-h3, a Transforming Growth Factor–β–Inducible Gene, Is Overexpressed in Atherosclerotic and Restenotic Human Vascular Lesions , 1996 .

[14]  Y. Akai,et al.  Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus , 1996 .

[15]  Jia Guo,et al.  Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice , 1996, Diabetes.

[16]  C. Nast,et al.  Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .

[17]  K. Sharma,et al.  Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator , 1995, Diabetes.

[18]  K. Sharma,et al.  Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. , 1994, The American journal of physiology.

[19]  K. Thai,et al.  Expression of transforming growth factor-β1 during diabetic renal hypertrophy , 1994 .

[20]  E. Ruoslahti,et al.  Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease , 1992, Nature.

[21]  L. Madisen,et al.  cDNA cloning and sequence analysis of βig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β , 1992 .

[22]  M. Sporn,et al.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.

[23]  A. Rizzino,et al.  Transforming growth factor-beta: multiple effects on cell differentiation and extracellular matrices. , 1988, Developmental biology.

[24]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[25]  J. H. Kim,et al.  Overexpression of the Transforming Growth Factor-b – Inducible Gene b igh 3 in Anterior Polar Cataracts , 2000 .

[26]  E. Schuuring,et al.  Multiple and sensitive fluorescence in situ hybridization with rhodamine-, fluorescein-, and coumarin-labeled DNAs. , 1993, Cytogenetics and cell genetics.

[27]  K. Sharma,et al.  The transforming growth factor-beta system and the kidney. , 1993, Seminars in nephrology.

[28]  J. Noh,et al.  Urine transforming growth factor-beta activity is related to the degree of scarring in crescentic nephritis in the rabbit. , 1993, Nephron.

[29]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.